# Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders

> **NCT05718583** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 20 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DIETARY_SUPPLEMENT:** Butyrate

## Key facts

- **NCT ID:** NCT05718583
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2025-02-20
- **Final completion:** 2025-02-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718583, "Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05718583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*